To Curb PSE Diversion, Retailers Lead By Example With Emphasis On Tamper-Resistant Products
This article was originally published in The Tan Sheet
An HHS agency’s 2013 drug use survey shows the number of meth users rising by 155,000 after changing little the previous two years. Acura Pharmaceuticals notes the survey and Tennessee data showing that making only tamper-resistant, single-ingredient PSE products available affects the diversion rate.
You may also be interested in...
While FDA decision on first birth control pill proposed for OTC sales in US should be based entirely on safety and efficacy data, same likely won’t be true for lawmakers in some states, particularly already banning or limiting access to abortions services and medications, say former FDA lawyers.
Senate Appropriations subcommittee members add to Capitol Hill's push for FDA to change its current regulatory stance that CBD is deemed noncompliant for use in supplements and food. Commissioner Gottlieb suggests legislation authorizing FDA to allow use of CBD up to certain concentrations in supplements and food products. FDA currently allows sales of food and supplements containing CBD under enforcement discretion.
US House legislation banning the sale of DXM OTCs to consumers under age 18 likely stands the same chance right now as previous versions that have failed, but CHPA expects an increasing number of state laws could spur future action.